Interestingly, the CD30-positive tumor cells of the EBV-associated DLBCL were significantly faster (5.58 μm/min) than the CD30-positive tumor cells in MGZL (2.69 μm/min, p < 0.05, Kruskal–Wallis test with Dunn’s post-test for multiple comparisons; Supplementary Figure S1). The gene discussed is TNFRSF8; the disease is diffuse large B-cell lymphoma.